Cortisol Cutoff for Critical Illness-Induced Hypocortisolism
The 2017 SCCM/ESICM guidelines indicate that either a random plasma cortisol <10 μg/dL OR a delta cortisol <9 μg/dL (change from baseline at 60 minutes after 250 μg cosyntropin administration) may be used to diagnose critical illness-related corticosteroid insufficiency (CIRCI), though the task force could not reach consensus on which test is superior. 1
Key Diagnostic Thresholds
The most authoritative guidance comes from the 2017 joint SCCM/ESICM guidelines, which reference the 2008 criteria:
- Random total cortisol: <10 μg/dL suggests CIRCI
- Delta cortisol after ACTH stimulation: <9 μg/dL (using 250 μg cosyntropin, measured at 60 minutes) suggests CIRCI
Important Caveats and Clinical Context
The guidelines explicitly make NO recommendation on whether to use delta cortisol versus random cortisol, as the task force could not achieve >80% consensus. This reflects fundamental uncertainty about whether a single test can reliably diagnose CIRCI given the heterogeneous mechanisms involved (altered cortisol synthesis, metabolism, or tissue resistance). 1
Evidence Supporting These Cutoffs
Multiple prospective cohort studies demonstrated that patients meeting these criteria (cortisol <10 μg/dL or delta <9 μg/dL) had:
- Poorer clinical outcomes
- Longer vasopressor requirements
- Higher mortality rates
- Greater need for catecholamines and fluid resuscitation
Critical Pitfalls to Avoid
Don't rely solely on ACTH stimulation testing for treatment decisions: The Surviving Sepsis Campaign guidelines specifically recommend against using the ACTH stimulation test to select which septic shock patients receive hydrocortisone. 1
Assay-specific considerations: The historical cutoff of 18 μg/dL for peak cortisol after ACTH stimulation (used for primary adrenal insufficiency) is assay-dependent and may be lower (14-15 μg/dL) with newer specific immunoassays or LC-MS/MS methods. 1, 2
Baseline cortisol matters for prognosis: Nonsurvivors in septic shock had higher baseline cortisol levels (29.5 vs 24.3 μg/dL) but lower delta cortisol responses, suggesting that the inability to mount an appropriate incremental response is more concerning than the absolute baseline value. 3
Alternative Testing Approaches (Not Recommended)
The guidelines suggest against using:
- Free cortisol over total cortisol (conditional recommendation, very low quality evidence) - cumbersome techniques, inconsistent findings, not readily available 1
- Salivary cortisol over serum cortisol (conditional recommendation, very low quality evidence) - practical issues with sample collection, contamination, limited availability 1
Evolving Understanding
Recent research (2019-2022) challenges the traditional CIRCI concept, suggesting that:
- High cortisol availability in acute critical illness is driven more by suppressed cortisol binding and reduced breakdown rather than increased production 4, 5, 6
- In prolonged critical illness (weeks), central adrenal insufficiency may develop from sustained ACTH suppression 4, 5
- The cosyntropin test may be confounded by increased cortisol distribution volume in ICU patients 5
Practical Clinical Approach
For acute septic shock: Consider CIRCI if random cortisol <10 μg/dL in a patient with refractory hypotension despite adequate fluid resuscitation and moderate-to-high dose vasopressors. Treatment decisions should be based on clinical presentation rather than waiting for ACTH stimulation test results. 1, 7
For prolonged critical illness: Be aware that central adrenal insufficiency may develop after weeks of ICU stay, particularly in patients on opioids or with sustained high glucocorticoid exposure. 4
The high-dose (250 μg) ACTH stimulation test is preferred over low-dose (1 μg) testing due to easier practical implementation and comparable accuracy. 1